Abstract
Abstract
For many years, wire-guided localization represented the gold standard method for the detection of non-palpable breast lesions, despite the acknowledged limitations. LOCalizer™ is the most recent and promising radiofrequency identification system, characterized by the capability of measuring the distance from the tagged lesion in millimeters and the association of each marker with a unique code. A 45-year-old woman with two lesions suspected of cancer in the same breast was referred to our department. She underwent double localization with LOCalizer™ (Hologic, Santa Carla, CA, USA) of the lumps into opposite quadrants. We performed a mini-invasive and oncologically safe surgical excision through a tunneling approach after a peri-areolar incision. The surgical technique realized with Localizer™ could be an effective method for locating multiple non-palpable breast lesions and is able to offer excellent oncological and cosmetic results, as also confirmed by several reports in the literature.
Funder
Università degli Studi della Campania Luigi Vanvitelli
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Chan BK, Wiseberg-Firtell JA, Jois RH, Jensen K, Audisio RA (2015) Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Database Syst Rev 31(12):CD009206. https://doi.org/10.1002/14651858.CD009206.pub2
2. Tardioli S, Ballesio L, Gigli S, DI Pastena F, D’Orazi V, Giraldi G et al (2016) Wire-guided localization in non-palpable breast cancer: results from monocentric experience. Anticancer Res 36(5):2423–2427
3. Hayes MK (2017) Update on preoperative breast localization. Radiol Clin North Am 55(3):591–603. https://doi.org/10.1016/j.rcl.2016.12.012
4. Cullinane CM, Byrne J, Akmenkalne L, O’ Leary DP, Connors AM, Corrigan MA et al (2021) The LOCalizer radiofrequency identification system: an effective new technology for localizing non-palpable breast lesions for surgery. Surg Innov 28(4):473–478. https://doi.org/10.1177/1553350620967853
5. Nuclear Regulatory Commission. Iodine-125 and Palladium-103 low dose rate brachytherapy seeds used for localization of non-palpable lesions n.d. https://www.nrc.gov/materials/miau/med-use-toolkit/seed-localization.html (Accessed 7 Aug 2018)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献